AN2 Therapeutics Inc (ANTX) — Financial Flexibility Index
AN2 Therapeutics Inc (ANTX) has a Financial Flexibility Index of -0.59x as of December 2025. Free cash flow of $-5.24 Million (operating CF $-5.24 Million minus capex $0.00) represents -1% of total liabilities ($8.89 Million). Also explore AN2 Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AN2 Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for AN2 Therapeutics Inc across 7 annual periods. Check AN2 Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for AN2 Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for AN2 Therapeutics Inc. For the full company profile including market capitalisation, see AN2 Therapeutics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-29.83 Million | $-29.83 Million | $8.89 Million | ▲ +30.2% |
| 2024 | -4.81x | $-49.26 Million | $-49.26 Million | $10.24 Million | ▼ -26.8% |
| 2023 | -3.79x | $-53.29 Million | $-53.29 Million | $14.04 Million | ▲ +18.5% |
| 2022 | -4.66x | $-33.46 Million | $-33.46 Million | $7.19 Million | ▲ +22.5% |
| 2021 | -6.01x | $-20.48 Million | $-20.48 Million | $3.41 Million | ▼ -66.2% |
| 2020 | -3.62x | $-5.36 Million | $-5.36 Million | $1.48 Million | ▼ -29.1% |
| 2019 | -2.80x | $-2.49 Million | $-2.49 Million | $887.00K | — |